I'm a spine doctor — beware this surprising cause of back pain, and what you can do to improve it
An estimated 80% of Americans will experience back pain at some point in their lives — and for around 16 million of those adults, the issue is chronic and with no easy end in sight.
While incredibly common, back pain is notoriously difficult to treat because 'it may be caused by multiple overlapping factors that cannot always be visualized on a scan,' Dr. Patricia Zheng, a physical medicine and rehabilitation specialist, told Medical Xpress.
3 Back pain is difficult to treat because it has so many different causes — and this one is frequently overlooked.
New Africa – stock.adobe.com
Some common causes of back pain include muscle strain, herniated discs, sprains, arthritis, poor posture, obesity, lack of exercise and even stress.
But, according to Zheng, one of the most overlooked causes of chronic back pain isn't physical at all — it's psychological.
'In a 2024 study, we identified smoking, alcohol, obesity, sleep disturbance and depression as risk factors for chronic back pain,' she told the outlet.
'I think some patients are surprised that depression, which may be associated with sleep disturbances, is linked to back pain.'
Depression can often make pain feel more severe, which is why she recommends seeing a therapist or taking antidepressants to patients who consistently feel down.
'Studies show that the neurotransmitters that play a role in depression and anxiety are also involved in the way we process pain, so taking an antidepressant may dampen the nervous system's overreaction to pain,' she said.
3 'I think some patients are surprised that depression, which may be associated with sleep disturbances, is linked to back pain,' Zheng said.
fizkes – stock.adobe.com
A recent study found only one out of every 10 treatments to be effective in relieving lower back pain, so the condition often needs to be tackled in a myriad of ways.
Firstly, Zheng recommends exercising — but not too strenuously, as research has shown that can actually make things worse.
'I can't emphasize enough how important it is to stay active,' she said, adding that she personally rotates between Pilates, aerobics and light weightlifting five days a week.
'But I'm not perfect; when life gets busy, I slack off.'
When you're in the office, she suggests maintaining good posture and getting up from your desk once every hour to move around 'because prolonged sitting puts pressure on the spinal disks.'
As for those trendy standing desks? Some studies show they can help relieve back pain, but there's more science behind simply going for a walk.
In fact, a recent Norwegian study showed that walking 100 minutes per day was associated with a 23% lower risk of chronic lower back pain.
3 Dr. Patricia Zheng is a physical medicine and rehabilitation specialist.
UCSF
If your back pain is due to an injury, Zheng emphasizes the importance of easing back into activity.
'The problem is, if you don't move, you get deconditioned,' she told the outlet.
'That can make you more susceptible to future injuries.'
In some extreme cases, minimally invasive surgeries or steroid injections might be recommended.
Meanwhile, some people have successfully relieved back pain by following an anti-inflammatory diet, which means eliminating things like sugar, red meat and alcohol.
Although Zheng herself is no stranger to temptation.
'I try to eat a balanced diet, but for me personally, I love sweets,' she said.
'I'm not going to pass on the dessert!'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
New Data Show Better Outcomes for Hospitalized Surgical Patients
WASHINGTON--(BUSINESS WIRE)--Patients in the hospital for surgeries had better outcomes in 2024 than they did in 2019, according to a new report released today by the American Hospital Association and Vizient®. The significant improvement aligned not only with better performance on patient safety metrics — such as reductions in infections and falls — but also with marked declines in three major surgical patient safety indicators: severe bleeding, sepsis and respiratory failure. The new findings build on a report AHA released in collaboration with Vizient last year showing that hospitals and health systems performed better on key patient safety and quality measures in the first quarter of 2024 than they did before the COVID-19 pandemic. In fact, hospitals' efforts to improve safety led to 200,000 Americans hospitalized between April 2023 and March 2024 surviving episodes of care they wouldn't have in 2019. 'The safety and quality improvements in surgical outcomes underscore the resilience and unwavering commitment of hospitals and health systems — and the millions of hospital team members across the country — to delivering better care to the patients and communities they serve,' said AHA President and CEO Rick Pollack. 'While hospitals are proud of these efforts, we know there is always more work to do to deliver the highest quality care possible.' 'These results of this analysis reflect the extraordinary efforts by hospitals to adapt and elevate surgical care,' said David Levine MD, Senior Vice President and Chief Medical Officer for Vizient. 'By leveraging advanced analytics and technology-driven insights, health systems are not only addressing the increasing complexity of inpatient surgical cases but are improving outcomes in meaningful, measurable ways.' KEY FINDINGS FROM TODAY'S REPORT In the first quarter of 2024, hospitalized surgical patients were nearly 20% more likely to survive than expected — based on the severity of their illnesses — compared to patients in the fourth quarter of 2019. This significant improvement aligned not only with better performance on patient safety metrics — such as reductions in infections and falls — but also with declines in three high-risk post-operative complications: hemorrhage (down 22.6%), sepsis (down 9.2%) and respiratory failure (down 18.9%). As an increasing number of surgical procedures shift to outpatient or ambulatory settings, the surgical patients who remain hospitalized tend to have greater clinical complexity and require higher acuity care. Vizient projects that this trend will continue to intensify over the next decade. The average length of stay for hospitalized surgical patients has increased by nearly one full day over the past five years. This rise correlates with increasing patient acuity and the concerning trend among commercial insurers to delay discharges and deny coverage for appropriate post-acute care services. About Vizient, Inc. Vizient, Inc., the nation's largest provider-driven healthcare performance improvement company, serves more than 65% of the nation's acute care providers, including 97% of the nation's academic medical centers, and more than 35% of the non-acute market. The Vizient contract portfolio represents $140 billion in annual purchasing volume enabling the delivery of cost-effective, high-value care. With its acquisition of Kaufman Hall in 2024, Vizient expanded its advisory services to help providers achieve financial, strategic, clinical and operational excellence. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at About the American Hospital Association (AHA) The American Hospital Association (AHA) is a not-for-profit association of health care provider organizations and individuals that are committed to the health improvement of their communities. The AHA advocates on behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses and other caregivers – and the 43,000 health care leaders who belong to our professional membership groups. Founded in 1898, the AHA provides insight and education for health care leaders and is a source of information on health care issues and trends. For more information, visit the AHA website at
Business Wire
3 hours ago
- Business Wire
Butterfly Network Advances AI-Powered Aortic Valve and Aorta Screening with New Research and Training Tools
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced its role in new research demonstrating the potential for machine learning (ML) models to support early detection of aortic stenosis (AS) using handheld ultrasound devices. The study, conducted by Tufts Medical Center and published in European Heart Journal – Imaging Methods and Practice, demonstrates that a ML model fine-tuned for use on Butterfly iQ+ devices can achieve high accuracy in identifying AS. The findings support the value of ML model development, and ultimately, are a positive step toward portable screening for earlier detection of this life-threatening condition. Aortic stenosis, a narrowing of the aortic valve, affects over 13% of Americans over 75 years old and is often missed until it's advanced and symptomatic. Studies(1, 2) suggest that a significant number of AS cases remain undiagnosed, particularly among underserved and aging populations. This delay in diagnosis is associated with higher risk procedures, worse outcomes, and increased healthcare costs. As earlier identification and treatments of AS are increasingly associated with better patient outcomes, the need for upstream, accessible screening is critical. 'This research shows a promising path forward where lower-level providers, not just cardiologists or trained sonographers, could screen for aortic stenosis using AI-assisted handheld ultrasound,' said Dr. John Martin, co-author of the study and Butterfly's Chief Medical Officer Emeritus. 'This opens the door to early detection in a wide variety of care venues including primary care offices, long term care facilities, urgent care facilities and even in the home.' The study validated that an ML model trained on hospital-grade ultrasound images performed well when adapted to Butterfly's handheld ultrasound device. After fine-tuning the final layer of a neural network, researchers achieved an area under the receiver operator characteristic curve (AUROC) of 0.94 for differentiating between no aortic stenosis and any degree of aortic stenosis on handheld ultrasound images – a level of accuracy that supports potential clinical use in screening workflows. In a related development, Butterfly has just released the latest expansion of its Butterfly ScanLab™ AI-powered ultrasound education app: an Aorta Exam Protocol. This educational app harnesses animations, anatomical labeling, and a quality indicator to help teach users how to scan the abdominal aorta and recognize normal anatomy. With that training, users can then use POCUS to detect life-threatening conditions like abdominal aortic aneurysms (AAA) and dissections. Designed for ease of use on an iPad, the module is included in every Butterfly membership and compatible with existing Butterfly probes. Joseph DeVivo, President, CEO, and Chairman of Butterfly Network concluded, 'Early detection saves lives, but access to imaging remains a major barrier. This work is about democratizing diagnostics. With AI and education working hand in hand, we're empowering more providers to deliver proactive care in places that were never possible before.' About Butterfly Network Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world's first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore's Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly's innovations have also been recognized by Fierce 50, TIME's Best Inventions and Fast Company's World Changing Ideas, among other achievements. Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit:
Newsweek
3 hours ago
- Newsweek
These Common Chemicals Could Be Harming Your Liver
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new review has found that exposure to particular chemicals can, when combined, enhance damage to the liver. The researchers of the July 2025 review, published in Toxicological Sciences, found that both alcohol and PFAS chemicals—a group of widely-used compounds—damage the liver in similar ways. This could be "causing fat buildup, inflammation, and oxidative stress," Vasilis Vasiliou, one of the authors of the review, and chair and professor of environmental health sciences at Yale School of Public Health, told Newsweek. While alcohol is a well-established cause of liver disease, PFAS chemicals may "act as a 'second hit,' especially in people who already drink alcohol or have other liver risk factors," he added. PFAS chemicals, also known as "forever chemicals" or Per- and polyfluoroalkyl substances, have been classified by the International Agency for Research on Cancer as a Group 1 carcinogen—with studies since finding the chemicals can cause a wide range of effects on public health. These chemicals can be found across various industries and consumer products, from nonstick cookware, waterproof clothing and stain-resistant furniture, to food packaging and even smartwatch wristbands. They can also be found in drinking water sources across the country. According to the review's researchers, detectable levels of PFAS chemicals have been found in over 98 percent of the human population. Meanwhile, more than half of all Americans drink alcohol—with 17 percent binge drinking, meaning, for women, they have four or more drinks on one occasion, while for men, they have five or more drinks, according to Centers for Disease Control and Prevention (CDC) data. Per the CDC's data, 6 percent also drink heavily, meaning, for women, they have eight or more drinks in a week and for men, they have 15 or more drinks. According to the review's researchers, while global consumption of alcohol has been decreasing since 2010, in the U.S. there has been an increase in consumption, meaning it is now nearly double the global average. File photo: A gastroenterologist doctor explaining liver and gallbladder problems using an anatomical model to a patient during a clinic visit. File photo: A gastroenterologist doctor explaining liver and gallbladder problems using an anatomical model to a patient during a clinic visit. peakSTOCK/Getty Images What The Review Found When people are exposed to both alcohol and PFAS chemicals, these "effects can add up or even multiply, leading to more serious liver injury," Vasiliou said. He added that vulnerable populations, or those with limited health care access, are particularly at risk. "Our review suggests that PFAS exposure may worsen the damage already caused by alcohol, raising the risk of progression from fatty liver to more severe conditions like cirrhosis or liver cancer," he said. The review noted that around two million deaths a year are estimated to occur due to advanced liver disease, predominantly cirrhosis and hepatocellular carcinoma, with alcohol consumption being a significant risk factor for these conditions. Alcohol contributed to nearly half of all cirrhosis deaths and over 150,000 new cases of liver cancer globally in 2016. "The findings are not unexpected," Dr. Suthat Liangpunsakul, a professor of medicine and of biochemistry and molecular biology at the Indiana University School of Medicine, told Newsweek. "Both alcohol and PFAS have independently been shown to affect the liver through mechanisms such as oxidative stress, lipid dysregulation, and mitochondrial dysfunction," Liangpunsakul said. "Given these overlapping pathways, the possibility that combined exposures may exacerbate liver injury is a reasonable hypothesis," he added. Liangpunsakul said the study therefore "brings together existing evidence in a way that highlights the need for further investigation." It adds to the "body of literature suggesting that multiple exposures, including lifestyle and environmental factors, can interact in complex ways to affect liver health," he said. However, "further research, particularly in human populations, will be important to better characterize these interactions and their potential clinical implications," he added. Vasiliou said that he and the other researchers in the laboratory are continuing to investigate the impact of PFAS chemicals on the liver in animal models and intend to expand research to human studies. In this photo illustration, water flows from a tap on July 06, 2023 in San Anselmo, California. In 2023, a study by the US Geological Survey found that nearly half of the tap water in... In this photo illustration, water flows from a tap on July 06, 2023 in San Anselmo, California. In 2023, a study by the US Geological Survey found that nearly half of the tap water in the United States was contaminated with "forever chemicals," considered dangerous to human health. More/Getty Images How PFAS Chemicals And Alcohol Could Harm The Liver PFAS chemicals may harm the liver by "disturbing fat metabolism, damaging mitochondria, increasing oxidative stress, and triggering inflammation," Vasiliou said, adding these were many of the same processes affected by alcohol. Liangpunsakul also said that PFAS chemicals "can accumulate in the liver" and cause the same problems mentioned by Vasiliou. Meanwhile, "alcohol has long-established and well-characterized hepatotoxic effects, particularly in the setting of chronic use," Liangpunsakul said. Therefore, the "real danger lies in their combined impact," Vasiliou said. "Together, they can accelerate liver damage in ways that neither might do alone." Liangpunsakul said that it is difficult to compare the "relative toxicity" of alcohol and PFAS, "as they operate under different exposure contexts and time courses." However, based on the review, he said that "PFAS may contribute additional stress to the liver, particularly in individuals with other risk factors such as alcohol use." While PFAS chemicals are in a wide range of everyday products, the most common way people are exposed to PFAS chemicals is through ingestion, Vasiliou said. "PFAS often enter our bodies through contaminated drinking water; food, especially fish [and] meat; fast-food packaging; and household products like nonstick cookware or stain-resistant fabrics," he said. Once ingested, PFAS chemicals can "circulate in the blood and accumulate in the liver, where they can persist for years due to their resistance to breakdown," he added. Those who are also occupationally exposed to the chemicals due to their work, such as firefighters or factory workers, may also "inhale PFAS or absorb them through the skin," he said. How Could The Research Shape The Treatment of Liver Disease? Liangpunsakul said the review highlights a growing area of scientific interest—"how environmental exposures might interact with more traditional risk factors like alcohol." He said that while "it is too early to say how this will influence clinical practice," the findings "may help guide future research into liver disease progression and its multifactorial drivers." "Improved understanding of co-exposures could eventually contribute to more refined risk assessment strategies," he added. The research also suggests that increasing awareness on individual PFAS exposure may become an important part of maintaining health. "For people with liver risk factors, such as alcohol abuse use or obesity, minimizing PFAS exposure could be especially important," Vasiliou said. However, "avoiding PFAS completely is difficult because they are so widespread, but people can take steps to reduce exposure," he added. He said individuals can use PFAS-free cookware and personal care products, filter drinking water with systems certified to remove PFAS, and check local advisories about contaminated water or fish. On a broader level, Vasiliou said that "stronger policies and better regulation are needed to reduce PFAS in our environment." Reference Arthur D Stem, Ricardo Scheufen Tieghi, Vaia Lida Chatzi, Nicole Kleinstreuer, Damaskini Valvi, David C Thompson, Vasilis Vasiliou, (2025). Synergistic Toxicity in Alcohol-Associated Liver Disease and PFAS Exposure, Toxicological Sciences,
